Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Achalasia.

Peter M. Dunaway1, Roy K. H. Wong

  • 1Gastroenterology Service, Walter Reed Army Medical Center, 6900 Georgia Avenue, NW, Washington, DC 20307-5001, USA.

Current Treatment Options in Gastroenterology
|February 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infectious Esophagitis.

Current treatment options in gastroenterology·2003
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Pneumatic dilation is the most cost-effective achalasia treatment over five years, offering over 90% success. Botulinum toxin (Botox) and laparoscopic myotomy are alternatives, with Botox reserved for high-risk patients.

Area of Science:

  • Gastroenterology
  • Digestive Diseases
  • Esophageal Disorders

Background:

  • Achalasia treatment is challenging due to patient-specific variables.
  • Treatment options include medical (pharmacologic, pneumatic dilation) and surgical approaches.

Purpose of the Study:

  • To review optimal treatment strategies for achalasia.
  • To compare the efficacy and cost-effectiveness of different achalasia therapies.

Main Methods:

  • Review of medical and surgical treatment options for achalasia.
  • Assessment of pneumatic dilation, laparoscopic myotomy, and botulinum toxin (Botox) therapy.
  • Analysis of patient variables, success rates, and cost-effectiveness over a 5-year period.

Main Results:

Related Experiment Videos

  • Pneumatic dilation with graduated dilator sizes is successful in over 90% of patients.
  • Botulinum toxin (Botox) requires repeat treatment every 3-6 months and is cost-effective for specific patient groups.
  • Laparoscopic myotomy is considered for patients unresponsive to medical therapy or unwilling to undergo pneumatic dilation.

Conclusions:

  • Pneumatic dilation is the most cost-effective achalasia treatment over five years.
  • Botox therapy is a viable option for select patients, particularly those with increased surgical risk or limited life expectancy.
  • Treatment decisions should be individualized based on patient factors, symptom response, and cost-effectiveness.